EMBL-EBI | Chemical Biology | ChEBI
Example searches: iron*, InChI=1S/CH4O/c1-2/h2H,1H3, caffeine | Advanced Search
CHEBI:6904 - metoprolol
| Formula | C15H25NO3 |
| Net Charge | 0 |
| Average Mass | 267.369 |
| Monoisotopic Mass | 267.18344 |
| SMILES | COCCc1ccc(OCC(O)CNC(C)C)cc1 |
| InChI | InChI=1S/C15H25NO3/c1-12(2)16-10-14(17)11-19-15-6-4-13(5-7-15)8-9-18-3/h4-7,12,14,16-17H,8-11H2,1-3H3 |
| InChIKey | IUBSYMUCCVWXPE-UHFFFAOYSA-N |
| Wikipedia |
|---|
| Roles Classification |
|---|
| Chemical Roles: | environmental contaminant Any minor or unwanted substance introduced into the environment that can have undesired effects. Bronsted base A molecular entity capable of accepting a hydron from a donor (Brønsted acid). |
| Biological Roles: | anti-HIV agent An antiviral agent that destroys or inhibits the replication of the human immunodeficiency virus. anti-obesity agent Any substance which is used to reduce or control weight. xenobiotic A xenobiotic (Greek, xenos "foreign"; bios "life") is a compound that is foreign to a living organism. Principal xenobiotics include: drugs, carcinogens and various compounds that have been introduced into the environment by artificial means. beta-adrenergic antagonist An agent that binds to but does not activate β-adrenergic receptors thereby blocking the actions of endogenous or exogenous β-adrenergic agonists. β-Adrenergic antagonists are used for treatment of hypertension, cardiac arrhythmias, angina pectoris, glaucoma, migraine headaches and anxiety. |
| Applications: | dermatologic drug A drug used to treat or prevent skin disorders or for the routine care of skin. antineoplastic agent A substance that inhibits or prevents the proliferation of neoplasms. antiatherosclerotic agent A cardiovascular drug that prevents atherosclerosis (a disease in which the inside of an artery narrows due to the build up of plaque). Compare with antiatherogenic agent. anti-arrhythmia drug A drug used for the treatment or prevention of cardiac arrhythmias. Anti-arrhythmia drugs may affect the polarisation-repolarisation phase of the action potential, its excitability or refractoriness, or impulse conduction or membrane responsiveness within cardiac fibres. antihypertensive agent Any drug used in the treatment of acute or chronic vascular hypertension regardless of pharmacological mechanism. beta-adrenergic antagonist An agent that binds to but does not activate β-adrenergic receptors thereby blocking the actions of endogenous or exogenous β-adrenergic agonists. β-Adrenergic antagonists are used for treatment of hypertension, cardiac arrhythmias, angina pectoris, glaucoma, migraine headaches and anxiety. hypoglycemic agent A drug which lowers the blood glucose level. antipsoriatic A drug used to treat psoriasis. geroprotector Any compound that supports healthy aging, slows the biological aging process, or extends lifespan. cardiovascular drug A drug that affects the rate or intensity of cardiac contraction, blood vessel diameter or blood volume. |
| ChEBI Ontology |
|---|
| Outgoing Relation(s) |
| metoprolol (CHEBI:6904) has role anti-arrhythmia drug (CHEBI:38070) |
| metoprolol (CHEBI:6904) has role anti-HIV agent (CHEBI:64946) |
| metoprolol (CHEBI:6904) has role anti-obesity agent (CHEBI:74518) |
| metoprolol (CHEBI:6904) has role antiatherosclerotic agent (CHEBI:145947) |
| metoprolol (CHEBI:6904) has role antihypertensive agent (CHEBI:35674) |
| metoprolol (CHEBI:6904) has role antineoplastic agent (CHEBI:35610) |
| metoprolol (CHEBI:6904) has role antipsoriatic (CHEBI:50748) |
| metoprolol (CHEBI:6904) has role cardiovascular drug (CHEBI:35554) |
| metoprolol (CHEBI:6904) has role dermatologic drug (CHEBI:50177) |
| metoprolol (CHEBI:6904) has role environmental contaminant (CHEBI:78298) |
| metoprolol (CHEBI:6904) has role geroprotector (CHEBI:176497) |
| metoprolol (CHEBI:6904) has role hypoglycemic agent (CHEBI:35526) |
| metoprolol (CHEBI:6904) has role xenobiotic (CHEBI:35703) |
| metoprolol (CHEBI:6904) has role β-adrenergic antagonist (CHEBI:35530) |
| metoprolol (CHEBI:6904) is a aromatic ether (CHEBI:35618) |
| metoprolol (CHEBI:6904) is a propanolamine (CHEBI:35533) |
| metoprolol (CHEBI:6904) is a secondary alcohol (CHEBI:35681) |
| metoprolol (CHEBI:6904) is a secondary amino compound (CHEBI:50995) |
| IUPAC Name |
|---|
| 1-[4-(2-methoxyethyl)phenoxy]-3-(propan-2-ylamino)propan-2-ol |
| Synonyms | Source |
|---|---|
| 1-(isopropylamino)-3-[4-(2-methoxyethyl)phenoxy]propan-2-ol | ChEBI |
| CGP-2175 | ChEMBL |
| H-93/26 | ChEMBL |
| Lopressidone | ChEMBL |
| Metoprolol | KEGG COMPOUND |
| Metoprolol | KEGG DRUG |
| Manual Xrefs | Databases |
|---|---|
| 1786 | DrugCentral |
| C07202 | KEGG COMPOUND |
| D02358 | KEGG DRUG |
| DB00264 | DrugBank |
| HMDB0001932 | HMDB |
| LSM-1259 | LINCS |
| Metoprolol | Wikipedia |
| Registry Numbers | Sources |
|---|---|
| Reaxys:1117585 | Reaxys |
| CAS:37350-58-6 | KEGG COMPOUND |
| CAS:37350-58-6 | ChemIDplus |
| CAS:51384-51-1 | ChemIDplus |
| CAS:51384-51-1 | KEGG COMPOUND |
| Citations |
|---|